Abstract:The Hippo pathway plays an evolutionarily conserved fundamental role in controlling organ size in multicellular organisms. Importantly, evidence from studies of patient samples and mouse models clearly indicates that deregulation of the Hippo signaling pathway plays a crucial role in the initiation and progression of many different types of human cancers. The Hippo signaling pathway is regulated by various stimuli, such as mechanical stress, G-protein coupled receptor signaling, and cellular energy status. When activated, the Hippo kinase cascade phosphorylates and inhibits the transcription co-activator YAP (Yes-associated protein), and its paralog TAZ (transcriptional coactivator with PDZ-binding motif), resulting in their cytoplasmic retention and degradation. When the Hippo signaling pathway is inactive, dephosphorylated YAP/TAZ translocate into the nucleus and activate gene transcription through binding to TEAD (TEA domain) family and other transcription factors. Such changes in gene expression promote cell proliferation and stem cell/progenitor cell self-renewal but inhibit apoptosis, thereby coordinately promote increase in organ size, tissue regeneration, and tumorigenesis. In this review, we summarize the molecular mechanisms of the mammalian Hippo signaling pathway with special emphasis on the Hippo kinase cascade and its upstream signals, the Hippo signaling pathway regulation of YAP and the mechanisms of YAP in regulation of gene transcription.

A ZO‐2 scaffolding mechanism regulates the Hippo signalling pathway

A ZO-2 scaffolding mechanism regulates the Hippo signalling pathway.

ZO-1 Regulates Hippo-Independent YAP Activity and Cell Proliferation via a GEF-H1- and TBK1-Regulated Signalling Network

MEKK2 and MEKK3 Orchestrate Multiple Signals to Regulate Hippo Pathway.

Inactivation of Yap Oncoprotein by the Hippo Pathway is Involved in Cell Contact Inhibition and Tissue Growth Control

Angiomotin is a Novel Hippo Pathway Component That Inhibits YAP Oncoprotein.

The Hippo-YAP Pathway in Organ Size Control and Tumorigenesis: an Updated Version.

Molecular mechanisms of the mammalian Hippo signaling pathway.

Zyxin-Siah2–Lats2 axis mediates cooperation between Hippo and TGF-β signalling pathways

Structural and functional insights into the TEAD-YAP complex in the Hippo signaling pathway

Phosphorylation of Angiomotin by Lats1/2 Kinases Inhibits F-actin Binding, Cell Migration, and Angiogenesis

Harness the power: new insights into the inhibition of YAP/Yorkie.

A molecular mechanism that links Hippo signalling to the inhibition of Wnt/β-catenin signalling

The Hippo-YAP pathway: new connections between regulation of organ size and cancer.

A Coordinated Phosphorylation By Lats And Ck1 Regulates Yap Stability Through Scf Beta-Trcp

Integration of Mechanical and Chemical Signals by YAP and TAZ Transcription Coactivators.

A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis.

The Hippo Pathway in Biological Control and Cancer Development

The YAP and TAZ transcription co-activators: key downstream effectors of the mammalian Hippo pathway.

Hippo and PI5P4K signaling intersect to control the transcriptional activation of YAP

Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling